Sort
82,697 grants matching “vaccine development”
Determination of Monkeypox LD50 and Pathogenesis
$970,861 · N01 · FY2010 · AI
Engineering Monodisperse Particulate Vaccines to Tailor Immunological Responses
$970,757Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · U19 · FY2016 · AI
Identification of key players mediating internalization of Trichomonas vaginalis extracellular vesicles by host cells and parasite adherence and survival in vivo
$970,686Patricia Jean Johnson · University Of California Los Angeles · R01 · FY2024 · AI
High accuracy automated tick classification using computer vision
$970,682Autumn Goodwin · Vectech, Llc · R44 · FY2025 · AI
Durable HIV Vaccine Targeting Mucosal Epithelium
$970,600Marie-Claire Elisabeth Gauduin · Texas Biomedical Research Institute · R01 · FY2024 · AI
Development of sG as a human vaccine against Nipah/Hendra
$970,588Timothy R Fouts · Profectus Biosciences, Inc. · R01 · FY2014 · AI
Virus-Host Interactions: Induction and Evasion of Host Innate Immunity
$970,517Sonja Best · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Malaria Immunology and Pathogenesis in Pregnant Women and Young Children
$970,501Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Universal Attenuated Sporozoite Vaccine and Challenge System
$970,426Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2017 · AI
Chemical Stabilization of shRNAs and their development as hepatitis C drugs
$970,401Brian H. Johnston · Somagenics, Inc. · R44 · FY2012 · AI
Novel TLR Ligand Mimetics as Adjuvants and Therapeutics
$970,322Michael D Gunn · Duke University · U19 · FY2007 · AI
Vaccine Development for Oral Carcinoma
$970,214University Of Pittsburgh At Pittsburgh · P01 · FY2004 · DE
Comprehensive Resources for HIV Microbicides and Biomedical Prevention: NHP Purchase and Holding
$970,160Peter Silvera · Advanced Bioscience Laboratories, Inc. · N01 · FY2022 · AI
Malaria Drug Resistance and Disease Virulence
$970,119Thomas E Wellems · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
NLM's Personal Health Record and Consumer Service R&D
$970,078Clement McDonald · National Library Of Medicine · ZIA · FY2010 · LM
Defining the immunogenic landscape of early mosquito-stage P. falciparum to accelerate malaria transmission-blocking vaccine discovery
$969,948Kristian Edward Swearingen · Institute For Systems Biology · R01 · FY2024 · AI
COVID Supplement - COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES,
$969,746Ted Ross · University Of Georgia · N01 · FY2020 · AI
RNA: New Antimicrobial Strategies
$969,159Adrian Ferrã-D'amarã · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
Uncleaved prefusion-optimized trimers on nanoparticles as HIV vaccines
$969,072Jiang Zhu · Scripps Research Institute, The · R01 · FY2022 · AI
Uncleaved prefusion-optimized trimers on nanoparticles as HIV vaccines
$969,072Jiang Zhu · Scripps Research Institute, The · R01 · FY2020 · AI
Uncleaved prefusion-optimized trimers on nanoparticles as HIV vaccines
$969,072Jiang Zhu · Scripps Research Institute, The · R01 · FY2023 · AI
Uncleaved prefusion-optimized trimers on nanoparticles as HIV vaccines
$969,072Jiang Zhu · Scripps Research Institute, The · R01 · FY2021 · AI
Vaccine Research and Development for Endemic, Emerging, and Resurgent Viruses
$969,000Masaru Kanekiyo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Integrating genomics and the protein interactome for HPV+ head and neck cancer therapy
$969,000Jennifer R Grandis · University Of California, San Francisco · R35 · FY2021 · CA
Discovering mechanisms of tissue-resident immune aging
$969,000Emily Lauren Goldberg · University Of California, San Francisco · DP2 · FY2025 · AI